LCM
COGT icon

Landscape Capital Management’s Cogent Biosciences COGT Stock Holding History

Landscape Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
5,541
-1,303
-19% -$48.1K 0.01% 627
2025
Q4 		$243K Buy
+6,844
New +$192K 0.02% 581
2024
Q1 		– Sell
-102,730
Closed -$604K – 785
2023
Q4 		$604K Buy
+102,730
New +$787K 0.05% 361

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Landscape Capital Management's COGT Position: Q1 2026 in Review

Landscape Capital Management reduced its Cogent Biosciences (COGT) stake by 19% in Q1 2026, selling an estimated $48.1K and leaving 5,541 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #627.

Landscape Capital Management first reported a position in COGT in Q4 2023 and has held it in 3 quarters since. The position peaked at $604K in Q4 2023. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Landscape Capital Management held 5,541 shares of Cogent Biosciences worth $213K as of Q1 2026.
  • Landscape Capital Management sold 1,303 Cogent Biosciences shares in Q1 2026, an estimated $48.1K.
  • Cogent Biosciences made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #627 holding.
  • Landscape Capital Management first reported a position in Cogent Biosciences in Q4 2023 and has held it in 3 quarters since.
  • Landscape Capital Management's Cogent Biosciences position peaked at $604K in Q4 2023.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.